FDA-Authorized Nicotine Pouches: The Complete 2026 List (ZYN, on! PLUS, Velo)

Nicozon may earn an affiliate commission when you purchase through links on this page, at no extra cost to you. Our editorial recommendations are based on clinical evidence, user data, and independent testing — never on commission rates. Read our full editorial standards.

For most of the last five years, the phrase “FDA-approved nicotine pouch” was technically a fiction. Pouch brands existed in a regulatory gray zone — sold legally under enforcement discretion, but not formally authorized by the U.S. Food and Drug Administration through the Premarket Tobacco Product Application (PMTA) pathway. That changed decisively across 2025 and the first half of 2026. The agency authorized 20 ZYN nicotine pouch SKUs in January 2025 (FDA, 2025) after the largest scientific review the Center for Tobacco Products has conducted on any oral product, and in December 2025 it greenlit the first six on! PLUS pouch SKUs as the inaugural decisions out of the agency’s pouch PMTA pilot program (FDA, 2025). Together those decisions reshape what “buy a safer pouch” actually means in 2026 — because for the first time, buyers can sort the market by whether the FDA has independently reviewed the product.

This guide is the complete, current list of FDA-authorized nicotine pouches in the United States as of May 2026, plus an honest assessment of which authorized SKUs are worth buying, what the authorization actually proves (and what it does not), and how to read the decisions when a brand markets itself as “FDA approved.” If you are already shopping for pouches and want a trust filter that is harder to fake than marketing copy, this is that filter.

What “FDA Authorized” Actually Means for a Nicotine Pouch

The FDA does not “approve” tobacco products in the way it approves drugs. It “authorizes” them through a Marketing Granted Order issued under the PMTA pathway, which requires the manufacturer to submit evidence that allowing the product to be sold is “appropriate for the protection of public health” — meaning it benefits adult users (typically smokers seeking lower-risk alternatives) more than it harms youth and non-users. A Marketing Granted Order is the only legal basis for selling a new tobacco product in the U.S. that was not on the market before February 15, 2007.

For nicotine pouches, every product currently on shelves was either submitted to PMTA review and is awaiting a decision, has received a Marketing Granted Order, or is being sold under the FDA’s enforcement discretion (legally precarious). The 20 ZYN SKUs and 6 on! PLUS SKUs authorized to date are the only nicotine pouch products in the U.S. with a final, affirmative FDA decision. Roughly 26 SKUs out of an estimated 4,000+ pouch products on the market, depending on how you count line extensions. The asymmetry matters: when a brand says “FDA approved,” in 2026 it almost certainly is referring to one of these two companies’ specific SKUs, not the brand as a whole.

It is also important to understand what the authorization does not prove. The FDA’s review found that ZYN’s products posed lower risk to users than cigarettes and that adult smokers switching to ZYN see meaningfully reduced exposure to harmful and potentially harmful constituents — but the agency was explicit that the products are “not safe” in absolute terms (FDA, 2025). The standard is comparative: lower risk than combustible tobacco, with adequate guardrails against youth uptake. If you are a current non-user reading this, the authorization is not a green light to start.

The 20 FDA-Authorized ZYN Nicotine Pouches

The FDA’s January 2025 Marketing Granted Order covered 20 specific ZYN SKUs — 10 flavors at 3 mg and the same 10 flavors at 6 mg. These are the products you will see most often on shelves with explicit “FDA-authorized” labeling.

The Authorized Flavor Lineup

Both 3 mg and 6 mg strengths cover the same ten flavors: Cool Mint, Wintergreen, Peppermint, Spearmint, Menthol, Smooth (unflavored tobacco), Chill (mint-menthol blend), Cinnamon, Coffee, and Citrus. Note that Cool Mint, Wintergreen, and Peppermint together account for roughly 70 percent of total ZYN volume according to retail scanner data (NielsenIQ, 2026), so most buyers are already in the authorized set whether they realized it or not.

What’s NOT in the Authorized Set

Several ZYN flavors that have been pulled in some markets — and some line extensions — are not in the Marketing Granted Order. If you see a ZYN SKU on a third-party site that does not match the ten flavors above, treat it as either grey-market (parallel imported from a non-U.S. market with different regulatory status) or as a SKU still under review. Our comprehensive ZYN pouches review breaks down which line extensions to favor and which to avoid.

Strength Recommendation

For new pouch users transitioning from vaping or cigarettes, 3 mg is almost always the right starting point. The 6 mg variants are appropriate for heavy combustible-tobacco users (≥1 pack/day equivalent) or experienced pouch users stepping down from snus. Our low-strength pouches taper guide explains how to use the 3 mg authorized variants for a structured nicotine reduction.

The 6 FDA-Authorized on! PLUS Nicotine Pouches

In December 2025, the FDA issued Marketing Granted Orders for six on! PLUS SKUs — the first decisions to come out of the agency’s pouch PMTA pilot program, which streamlined review for products with strong public-health data (FDA, 2025). on! PLUS is the larger, longer-duration sibling of the original on! pouch line, designed specifically to compete with ZYN on the parked-and-forget format that dominates daytime professional use.

The Authorized SKUs

The six authorized on! PLUS products are: Wintergreen 3 mg, Wintergreen 6 mg, Mint 3 mg, Mint 6 mg, Citrus 3 mg, and Citrus 6 mg. Notably absent from the initial authorization batch: any sweet-flavored variants, any menthol-only variants, and the higher-strength 8 mg tier that some on! PLUS products are sold at internationally.

How on! PLUS Compares to ZYN in Practice

The two authorized brands now occupy slightly different niches. ZYN’s slim and mini formats are smaller and produce less drip, making them the office-use default (covered in detail in our best nicotine pouches for work ranking). on! PLUS pouches are noticeably larger — closer to traditional snus dimensions — which delivers a stronger, more sustained nicotine release but generates more saliva and is more visible. For a side-by-side comparison of pouch dimensions, check our nicotine pouch brand comparison.

Child-Resistant Packaging Requirement

Every authorized on! PLUS product must ship in a certified child-resistant can with a safety lid — a packaging requirement the FDA imposed in response to a measurable rise in pediatric pouch ingestions reported to U.S. poison control centers (American Association of Poison Control Centers, 2025). Buyers should verify the packaging meets the child-resistant standard rather than the older twist-cap design, which is being phased out across the on! PLUS line by Q3 2026.

What About Velo, Rogue, VOLT, and Other Major Brands?

As of May 2026, no Velo, Rogue, VOLT, ZONE, BLCK, Lucy, or other independent brand has received a Marketing Granted Order from the FDA. Several have applications under active review, and the FDA’s pouch PMTA pilot is expected to issue another batch of decisions in late Q3 2026. Until that happens, those brands are sold under enforcement discretion — legal to purchase, but without an explicit federal review backing the safety claims.

This is not the same as saying those brands are unsafe; many manufacture to high standards and use the same nicotine and food-grade fillers as authorized SKUs. But it does mean the trust signal is weaker. If you specifically want a pouch with an FDA Marketing Granted Order behind it, the universe in 2026 is ZYN’s authorized 20 SKUs and on! PLUS’s authorized 6 SKUs — full stop.

For buyers who care more about flavor variety, lower-strength options, or specific harm-reduction profiles than about FDA paperwork, the unauthorized-but-established brands are still reasonable choices. Our roundup of the best nicotine pouches for beginners includes both authorized and unauthorized SKUs, ranked on practical criteria like drip control and onset time.

How the FDA’s Pouch Standard Differs From Vape and Cigarette Standards

A useful frame for understanding the 26 authorized pouch SKUs is the comparative review record across nicotine product categories. As of early 2026, the FDA had issued Marketing Granted Orders for fewer than 60 e-cigarette products total — out of more than 26 million applications submitted (FDA, 2026) — meaning the authorization rate for vape products has been below 0.001 percent. The pouch authorization rate is meaningfully higher because the modern oral nicotine pouch category is small (roughly 4,000 SKUs vs. millions of e-cigarettes) and because the public-health math is more favorable for combustion-free oral products.

In other words: an FDA-authorized vape and an FDA-authorized pouch are both rare, but the rarity reflects different things. For vapes, it reflects the agency’s deep skepticism about youth flavor migration; for pouches, it reflects a more constrained review pipeline working through a smaller universe of products. Buyers should not infer that “FDA-authorized” automatically means low-risk — it means the agency reviewed a specific dossier and concluded the public-health balance was favorable for that specific product.

Buying Authorized Pouches: Practical Tips

When shopping in 2026, three practical filters separate genuine FDA-authorized SKUs from grey-market parallels and from unauthorized line extensions sold under similar branding:

Verify the SKU name matches the authorized list. ZYN’s authorized set is the ten flavors at 3 mg and 6 mg listed above; on! PLUS’s authorized set is Wintergreen, Mint, and Citrus at 3 mg and 6 mg. Anything outside that list is not in the Marketing Granted Order, even if it is from the same brand.

Buy from U.S. retailers with documented chain of custody. Authorized SKUs sold through unlicensed third-party sellers may be parallel imports from non-U.S. markets where formulation differs (e.g., Swedish ZYN at 8 mg+ does not match the U.S. authorized SKUs). Stick to large retailers with verified supply chains.

Check packaging for the child-resistant lid. All on! PLUS authorized products and most ZYN authorized products ship in a certified child-resistant can. If the can twists open without resistance, the product is likely either grey-market or older inventory predating the requirement.

For pouch users transitioning from vaping or cigarettes, the authorization layer is one filter among several. Strength matching matters more than authorization status for a successful switch — see our guide to transitioning from vape to nicotine pouches for a structured approach. And for users worried about specific oral health concerns, our coverage of nicotine pouches and gum health addresses what the authorized SKUs do and do not protect against.

What’s Next: Pouches Pending Review

The FDA’s pouch PMTA pilot is expected to issue another batch of decisions in late Q3 2026, with industry analysts anticipating action on Velo, Rogue, and possibly VOLT (Tobacco Insider, 2026). A second wave is likely to roughly double the authorized pouch universe to ~50 SKUs — still a small fraction of products on shelves, but enough to materially change buyer behavior for users who treat FDA review as a buying filter.

We will update this list within 48 hours of any new Marketing Granted Order. Until then, the universe of FDA-authorized nicotine pouches in the United States remains: 20 ZYN SKUs and 6 on! PLUS SKUs. Twenty-six products, two manufacturers, one regulatory trust signal.

Are FDA-authorized nicotine pouches safer than other pouches?

The FDA’s Marketing Granted Orders confirm that authorized pouches pose lower risk than cigarettes for adult smokers who switch completely. The agency does not, however, claim authorized pouches are categorically safer than unauthorized pouches that use similar formulations. For most buyers, the practical safety difference between an authorized ZYN and an unauthorized Velo of equivalent strength is small; the authorization is more meaningful as a regulatory and supply-chain trust signal than as a product-quality differentiator.

Why hasn’t Velo received FDA authorization yet?

Velo has applications under active PMTA review but has not yet received a Marketing Granted Order as of May 2026. The FDA’s pouch PMTA pilot prioritized applications with the strongest existing public-health data, and ZYN and on! PLUS were the first companies to clear that bar. Decisions on Velo and other major brands are expected in late 2026.

Can I trust pouches that say “FDA approved” on the package?

Only if the specific SKU appears on the FDA’s published list of authorized products. As of May 2026, that list contains 20 ZYN SKUs (ten flavors at 3 mg and 6 mg) and 6 on! PLUS SKUs (Wintergreen, Mint, Citrus at 3 mg and 6 mg). Brands that market themselves as “FDA approved” without the SKU appearing on the authorized list are using inaccurate language, sometimes in violation of FDA labeling rules.

Will more nicotine pouches get FDA authorization in 2026?

Yes. The FDA’s pouch PMTA pilot is expected to issue additional Marketing Granted Orders in late Q3 2026. Industry analysts anticipate decisions on Velo, Rogue, and possibly VOLT, which would roughly double the authorized pouch universe. The FDA has also signaled interest in extending the pilot framework to additional applicants in 2027.

Does FDA authorization mean a pouch is safe to use long term?

No. FDA authorization establishes that a product is “appropriate for the protection of public health” relative to combustible tobacco — a comparative standard, not an absolute safety claim. Long-term effects of nicotine pouch use, particularly on oral health and cardiovascular outcomes, are still being studied. Authorized pouches reduce exposure to combustion-derived toxicants but do not eliminate nicotine’s pharmacological effects, including dependence and cardiovascular activation.